Sticker shock.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 23744133.
- Also identified by DOI 10.1038/nm.3244.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A recent plea by oncologists condemning inflated prices for some cancer drugs has ignited a debate on this topic between clinicians and pharmaceutical companies and highlights the need for a broader assessment of drug valuation.
Medical subject headings
- Antineoplastic Agents
- Drug Costs
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive